Background
A global pharmaceutical company headquartered in Asia was launching the next get platform-based Digital Therapeutics (DTx) solution that offers patients and HCPs better value over the legacy options. The primary objective of the solution was to collect data in a self-sustained manner with an eye on creating a break-even business model, growing the market, and establishing the company’s leadership in the associated therapeutic space. Our client’s aim was to develop an innovative Go-To-Market strategy that would meet both primary and secondary objectives.Â